Medical Advocates
 

Kaletra Library Service 
 Conference Abstracts and Posters
   
  Index of  Abstracts and Posters from 
12th Conference on Retroviruses and Opportunistic
Infections
 Boston. MA, USA
 February 22-25, 200r



 
Last Update:  December 22, 2005
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
 
Pediatric  Data
 
  POSTER
 6-Month Follow-up of Once-daily Lopinavir/ritonavir in HIV-infected Children
G. Verweel, M.J. van der Lee, DM. Burger, R. de Groot
PDF Poster     Abstract

POSTER
A Prospective Evaluation of Pharmacologic, Virologic, and Immunologic
Parameters of Lopinavir/Ritonavir for HIV-1-infected Infants < 6 Months of Age
 EG Chadwick, J Rodman, P Palumbo, et al
PDF Poster   Abstract

A Prospective Evaluation of Pharmacologic, Virologic, and Immunologic
Parameters of Lopinavir/Ritonavir for HIV-1-infected Infants < 6 Months of Age
EG Chadwick, J Rodman, P Palumbo, et al
Abstract

General Data

  POSTER
Virological Response and Resistance to Lopinavir/Ritonavir in Subtype-C Patients
Z Grossman, M Lorbe L Thibaut, et al
PDF Poster   Abstract

POSTER
Neither MDR1 Genotypes (C3435T, G2677T/A, C1236T) nor Hepatic and Intestinal
CYP 3A4 Activity Are Associated with Plasma and Intracellular Concentrations of
Lopinavir and Ritonavir
C Wyen, A Jetter, R Aarnoutse,  et al
PDF Poster   Abstract

POSTER
Kaletra Independently Reduces HIV Replication in Cerebrospinal Fluid
G van den Brande, J Marquie-Beck, E Capparelli
PDF Poster   Abstract     Commentary

Randomized Study of Twice-daily Lopinavir/ritonavir or Fosamprenavir +
Ritonavir vs Lopinavir/ritonavir + Fosamprenavir (with Tenofovir DF and
Nucleosides) as Rescue Therapy
A Collier, C Tierney, G Downey, et al
Abstract

The Association between Increasing Blood Pressure and Use of NNRTI and
Lopinavir/Ritonavir
H Crane, S Van Rompaey M Kitahata
Abstract
 
Evaluating in vitro the Effect of Amprenavir, Lopinavir, and Atazanavir with or
without a Low Concentration of Ritonavir Using Multiple Adipose Cell Function
Endpoints
 M Caron, M Auclair, C Lagathu, et al
Abstract
 
Randomized, Controlled Trial of Lopinavir/Ritonavir + Efavirenz vs Efavirenz + 2
Nucleoside Reverse Transcriptase Inhibitors following a First Suppressive 3- or
4-Drug Regimen in Advanced HIV Disease
M  Fischl, R Bassett, A Collier, et al
Abstract
KLS Main Page   KLS Conference  Index  Home

12th Conference on Retroviruses and Opportunistic Infections
 Index of Kaletra Data
© 2005 Medical Advocates for Social Justice